CHAPTERS
- 0:00 – 2:04
Metformin/DHEA/Growth Hormone study and the promise of age reversal
Joe and David open by discussing a small but headline-making study suggesting a cocktail of metformin, DHEA, and human growth hormone reduced participants’ biological age by ~2–2.5 years. Sinclair frames it as early evidence that aging might be reversible, not just slowed.
- •Study claims ~2 years off biological age (small n=9, needs replication)
- •Regular participants (not elite athletes), which makes results more broadly interesting
- •Idea shift: from slowing aging to potentially reversing it
- •Sinclair’s broader goal: determine whether aging is truly reversible
- 2:04 – 4:59
The Horvath epigenetic clock: how “biological age” is measured
Sinclair explains that biological age in the study wasn’t based on telomeres or performance, but on epigenetic marks on DNA (chemical modifications) captured by the Horvath Clock. He suggests these marks may be part of the aging mechanism and potentially modifiable.
- •Epigenetic modifications (esp. on cytosines) change predictably with age
- •AI-driven models can estimate biological age from blood DNA methylation patterns
- •Clock may predict mortality risk and reflect aging processes
- •If the clock is causal, reversing it could reverse aspects of aging
- 4:59 – 6:50
Antioxidants disappoint; resveratrol, sirtuins, and how to take it
Joe asks about antioxidants and resveratrol. Sinclair argues most antioxidant approaches have failed to extend lifespan, while resveratrol’s key action is signaling stress-response pathways via sirtuins, not simple antioxidant effects. They discuss dosage and absorption considerations.
- •Most antioxidant supplements fail to extend lifespan in organisms
- •Resveratrol acts mainly by activating sirtuins (defense/repair pathways)
- •Sinclair’s routine: ~1g resveratrol; capsules vs powder
- •Absorption improves with fat/protein (e.g., yogurt, whole milk)
- 6:50 – 8:54
NAD biology: CD38, NMN/NR, and combining interventions
They connect the study’s effects to NAD metabolism, highlighting CD38 as an NAD-degrading enzyme that increases with age. Sinclair discusses NMN as an NAD precursor, the need for combination trials, and uncertainties about stacking drugs with lifestyle interventions.
- •Treatment lowered CD38, potentially preserving NAD levels
- •NAD supports sirtuins; NAD decline may impair cellular defenses
- •NMN is an NAD precursor; NR is a related, often cheaper precursor
- •Open questions: best drug combos, timing, and interaction with exercise/fasting
- 8:54 – 12:59
Metformin and exercise: performance tradeoffs and “pulsing” strategy
Joe raises concerns that metformin (and even resveratrol) may blunt training adaptations. Sinclair explains a plausible mitochondrial mechanism and proposes cycling metformin—avoiding it on intense exercise days—to preserve fitness gains while keeping potential longevity benefits.
- •Evidence suggests metformin can reduce exercise-induced gains in some contexts
- •Hypothesis: metformin interferes with mitochondrial signaling/adaptation
- •“Pulse it”: use metformin on sedentary/travel days, skip on training days
- •Acknowledges uncertainty—edge of knowledge, mechanistic gaps remain
- 12:59 – 17:59
Heat/cold exposure, hormesis, alcohol, and Sinclair’s travel/workout reality
The conversation shifts into practical lifestyle: Sinclair’s limited training schedule, sauna/cold routines, and Joe’s hot yoga + cryotherapy habits. They touch on hormesis (beneficial stress), overdoing extremes, and alcohol as a common vice that impacts health and aging.
- •Sinclair’s workout: weights, stretching, hot/cold exposure (but infrequent)
- •Hormesis concept: stress can help, but extremes can harm
- •Alcohol: common habit; vacation overindulgence and visible aging effects
- •Recovery and consistency vs “too much” stress (sauna heat example)
- 17:59 – 34:56
Africa origins journey: predators, tribes, and the “natural vs unnatural” debate
A long detour becomes a philosophical thread: Sinclair’s family trip through Africa and into Israel, witnessing wildlife predation and meeting the Batwa (pygmy) communities. This leads to a critique of “aging is natural so it’s acceptable” and a defense of using science/technology to improve life.
- •Safari experiences: habituated animals, danger, predation realities
- •Batwa tribe displacement and need for support; tourism as subsistence
- •Argument: “natural” isn’t automatically good—modern life is already unnatural
- •Technology as an extension of human nature (tools, cities, medicine)
- 34:56 – 48:38
Religion, origin stories, and human behavior from Jerusalem to Kyrgyzstan
From Jerusalem to Mecca imagery, they explore why humans crave shared meaning and ritual. They discuss cultural traditions, sexism in religious spaces, and startling social practices (e.g., kidnapping-based marriages), contrasting scientific and religious ‘origin stories.’
- •Rituals as community glue: Kaaba circumnavigation, holy sites in Jerusalem
- •Observation: disproportionate men/women spaces at the Wailing Wall
- •Kyrgyzstan kidnapping-to-marriage practice as a modern cultural shock
- •Science vs religion as competing narratives of origins and meaning
- 48:38 – 1:10:17
Longevity limits, centenarians, and Sinclair’s father as a case study
They return to aging science: maximum lifespan records, genetic variants linked to longevity, and skepticism around extreme age claims. Sinclair describes his 80-year-old father’s remarkable fitness and supplement regimen, using it to illustrate ‘healthspan’ gains and psychological benefits of vitality.
- •Longevity genes (e.g., FOXO3) and the mixed lifestyles of centenarians
- •Jeanne Calment record controversy and why it may not matter practically
- •Sinclair’s father: NMN + metformin + resveratrol; high activity and optimism shift
- •Healthspan framing: productive elders reduce societal and healthcare burdens
- 1:10:17 – 1:20:08
Fasting, sirtuins, and quantified self: Oura ring, Apple Watch, glucose tracking
Sinclair explains how hunger/fasting activates longevity pathways (sirtuins) and contrasts constant calorie restriction with intermittent/periodic fasting. They discuss self-monitoring tools, blood tests, continuous glucose monitoring, and food-driven glucose spikes (including surprising culprits).
- •Fasting/calorie restriction extends lifespan in many organisms; mechanisms involve sirtuins/NAD
- •Intermittent fasting vs periodic fasting—best protocol still unclear
- •Wearables (Oura/Apple Watch) and lab tests to personalize decisions
- •Glucose monitors reveal individual responses; fruit and starch surprises
- 1:20:08 – 1:46:29
Food, microbiome, raw milk raids, resistant starch, and “xenohormesis”
The discussion broadens to diet quality: yogurt-making, raw vs processed dairy, fermented foods, and regulatory controversies. Sinclair introduces xenohormesis—the idea that plant stress compounds (polyphenols) signal resilience pathways in animals—connecting colorful foods and wine chemistry to longevity signaling.
- •Homemade yogurt and microbiome-targeted foods
- •Raw milk legality and safety debates; processed vs raw digestion differences
- •Resistant starch “potato hack” (cook-cool-reheat) to blunt glucose spikes
- •Xenohormesis: plant stress polyphenols (resveratrol/quercetin) as beneficial signals
- 1:46:29 – 1:50:24
Radiation, air travel, NAD precursors, and supplementation cautions
Sinclair warns that DNA damage from UV and certain radiation can accelerate epigenetic aging, recommending protection like sunscreen and caution with exposure. They discuss NMN/NR availability, his reluctance to endorse brands, and emphasize the limits of human evidence versus animal data.
- •DNA damage (UV/X-rays) as an aging driver via chromosomal breaks/epigenetic disruption
- •Sinclair takes NMN during flights; mentions protective effects in mouse radiation studies
- •Commercial NMN/NR exist; Sinclair won’t name brands and notes counterfeit association risks
- •Repeated caveat: promising biology, but human efficacy still not fully proven
- 1:50:24 – 1:54:50
CRISPR and gene therapy: from embryo edits to adult treatments
They move to frontier genetics: Sinclair explains CRISPR as programmable DNA editing and discusses controversial embryo editing to disable CCR5 for HIV resistance. The focus shifts to adult gene therapy already entering clinics—especially in eye diseases—setting the stage for rejuvenation approaches.
- •CRISPR: guide RNA directs a cutting enzyme to specific genome sites
- •Embryo editing controversy: unknown off-targets, long-term effects, risk/benefit concerns
- •Adult gene therapies emerging (e.g., treating vision loss, sickle cell breakthroughs)
- •Ethical and geopolitical concerns about enhancement and ‘superhuman’ selection
- 1:54:50 – 2:12:50
Reprogramming aging: Yamanaka factors, retina rejuvenation, and clinical timelines
Sinclair describes his lab’s work using partial cellular reprogramming (Yamanaka factors) delivered by AAV viruses to reset epigenetic age and restore function—demonstrated in mouse vision and optic nerve regeneration. He outlines realistic clinical paths starting with diseases like glaucoma/macular degeneration before elective ‘old-age’ rejuvenation.
- •Partial reprogramming can reverse epigenetic age without killing the organism (if done safely)
- •AAV delivery + drug-controlled activation (doxycycline) in mice restored vision
- •Optic nerve regrowth after injury suggests broader regenerative potential
- •Near-term plan: FDA-approvable trials in eye diseases; broader rejuvenation later
- 2:12:50 – 2:19:26
Senolytics and “zombie cells”: clearing senescence vs resetting identity
They close on another major anti-aging avenue: senolytics, drugs designed to remove senescent cells that drive inflammation and tissue dysfunction. Sinclair ties senescence to epigenetic identity loss and describes the state of companies and trials, positioning senolytics as a potentially nearer-term intervention than full reprogramming.
- •Senescent cells accumulate with age and secrete inflammatory factors (SASP)
- •Mouse studies: removing senescent cells can delay/reverse functional decline
- •Senolytics in development: Unity trials (osteoarthritis) and other preclinical efforts
- •Two complementary strategies: remove damaged cells (senolytics) vs reset epigenetic age (reprogramming)
